美国 Medicare 人群中乳腺癌肿块切除术后辅助放疗使用与实施的地域差异
基于 SEER-Medicare 数据库 2007 至 2011 年诊断的 13,176 例 66 至 79 岁淋巴结阴性早期乳腺癌接受保乳手术患者,按 NCCN 指南分为高危和低危,采用 5 种建模方法分析放疗使用及地域差异。高危患者放疗比例为 70.1%,低于低危患者的 72.6%(P=0.002);农村地区、黑人及亚洲患者接受放疗的 odds 较低,高危患者中地域变异较小。
要点
- 高危患者放疗比例 70.1%,低于低危患者的 72.6%(P=0.002)。
- 农村地区患者接受放疗的 OR 为 0.73(P<0.001),低于全体队列。
- 黑人患者 OR 为 0.73(P=0.001),亚洲患者 OR 为 0.74(P=0.004),均低于全体队列。
核心结论
- 研究观察到队列中放疗接受存在地域及种族和民族差异;令人欣慰的是,高危复发患者中放疗接受的地域变异较小;未来需开展工作以理解这些地域差异的原因,从而更好地服务可能获益于治疗的患者。
研究设计与样本
- 基于 SEER-Medicare 数据库识别 2007 至 2011 年诊断、年龄 66 至 79 岁、淋巴结阴性乳腺癌且接受保乳手术的患者 13,176 例。
- 按 National Comprehensive Cancer Network 指南将患者分为高危和低危复发风险。
- 采用 5 种建模方法研究放疗接受情况,并对每个结局进行多变量混合效应逻辑回归。
- 使用分级统计地图描述放疗使用模式。
主要发现
- 高危患者中 70.1% 接受放疗,低危患者中 72.6% 接受放疗(P=0.002)。
- 接受放疗的患者中 60.9% 为高危,未接受放疗的患者中 63.0% 为高危(P=0.002)。
- 多变量分析中,所有农村地区患者接受放疗的 OR 为 0.73(P<0.001),低于全体队列;同时为高危且接受放疗的 OR 为 0.69(P<0.001),低于全体队列。
- 黑人患者接受放疗的 OR 为 0.73(P=0.001),亚洲患者接受放疗的 OR 为 0.74(P=0.004),均低于全体队列。
- 预测所有患者接受放疗的模型地域组内相关系数(ICC)为 0.05,低危患者中为 0.06;预测同时为高危且接受放疗的模型地域 ICC 降至 0.02。
关键数值与推荐
- 高危患者放疗比例 70.1%,低危患者 72.6%(P=0.002)。
- 农村地区患者接受放疗 OR 0.73(P<0.001),同时为高危且接受放疗 OR 0.69(P<0.001)。
- 黑人患者接受放疗 OR 0.73(P=0.001),亚洲患者 OR 0.74(P=0.004)。
- 所有患者接受放疗模型地域 ICC 0.05,低危患者 0.06,高危且接受放疗模型地域 ICC 0.02。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
PURPOSE: We examined radiation therapy (RT) use among patients with early-stage breast cancer and analyzed the contribution of patient, cancer, and regional factors to the likelihood of RT receipt across Health Service Areas. METHODS AND MATERIALS: We identified 13,176 patients aged 66 to 79 years in the Surveillance, Epidemiology, and End Results (SEER) Program-Medicare database who were diagnosed with lymph node-negative breast cancer in 2007 to 2011 and were treated with breast-conserving surgery. Patients were stratified as being at high risk or low risk for recurrence based on National Comprehensive Cancer Network Guidelines. Receipt of RT was studied with 5 modeling approaches to determine whether RT use and regional variation in its use changed based on the risk level of the cohort. Multivariable mixed-effects logistic regression was performed for each outcome. Choropleth maps were used to describe patterns of RT use. RESULTS: Among high-risk patients, 70.1% received RT, compared with 72.6% of low-risk patients (P = .002). Among patients receiving RT, 60.9% were classified as high-risk, compared with 63.0% of patients who did not receive RT (P = .002). In multivariable analyses, patients in all rural areas had lower odds of receiving RT compared with the entire cohort (odds ratio [OR], 0.73; P < .001) and had lower odds of being high-risk and receiving RT (OR, 0.69; P < .001). Black patients (OR, 0.73; P = .001) and Asian patients (OR, 0.74; P = .004) had decreased likelihood of receiving RT compared with the entire cohort. The regional interclass correlation coefficient (ICC) for the model predicting receipt of RT among all patients was 0.05 and among low-risk patients was 0.06. The regional ICC dropped to 0.02 for the model predicting being both high-risk and receiving RT among all patients. CONCLUSIONS: We observed regional and racial and ethnic disparities in RT receipt among our cohort. Reassuringly, less regional variability was observed for RT receipt among those at high risk for recurrence. Future work is needed to understand the causes of these regional disparities to better serve patients who may benefit from treatment.
引用
- Lui G, Hassett MJ, Tramontano AC, et al. Regional Disparities in the Use and Delivery of Adjuvant Radiation Therapy after Lumpectomy for Breast Cancer in the Medicare Population. Adv Radiat Oncol. 2022. PMID: 36420195. doi:10.1016/j.adro.2022.101017
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。